Kevin Chinn serves as Vice President and Head of the Cell & Gene Therapy Service Line for Cencora. In his role, Kevin is responsible for leading Cencora’s strategy to support cell and gene therapy developers in commercializing their innovative products. Kevin also leads the team responsible for developing strategic partnerships with cell and gene therapy companies. Under Kevin’s leadership, his team positions themselves as a full end-to-end commercialization partner for cell and gene therapy companies, assessing the necessary resources at the appropriate time along their commercialization journeys.  Prior to his role at Cencora, Kevin held various leadership roles at CVS Health. Most recently, Kevin was responsible for commercialization, go-to-market strategy, and sales for their Home Health division. Before his time with Home Health, Kevin led Health System Alliances, where he created mutually beneficial business relationships with provider groups and IDNs across the country, utilizing all of CVS Health’s assets. Kevin has also held sales leadership roles at Medtronic and Abbott.  Kevin received his Bachelor of Science in Business Economics from the University of Arizona.